Case Report: Clinical complete response of advanced renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion by treated by camrelizumab and axitinib: A rare case report

Renal cell carcinoma (RCC) associated with Xp11.2 translocation/TFE3 gene fusions is a rare subtype of renal tumor. This entity predominantly occurs in juveniles, but rarely in adults. Xp11.2 translocation RCC (tRCC) patients with lymph node or organ metastasis are associated with poor prognosis, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Juping, Dai, Kun, Xie, Jialing, Fang, Chen, Chen, Na, Dai, Jun, Xu, Danfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403306/
https://www.ncbi.nlm.nih.gov/pubmed/36034832
http://dx.doi.org/10.3389/fphar.2022.927299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403306/
https://www.ncbi.nlm.nih.gov/pubmed/36034832
http://dx.doi.org/10.3389/fphar.2022.927299

Ejemplares similares